| Literature DB >> 34199126 |
Zhaoyu Zhang1, Lingyu Zhang1, Chengpeng Li1, Xiangyu Xie1, Guangfa Li1, Zhang Hu1, Sidong Li1.
Abstract
Chitosan is a linear polysaccharide produced by deacetylation of natural biopolymer chitin. Owing to its good biocompatibility and biodegradability, non-toxicity, and easy processing, it has been widely used in many fields. After billions of years of survival of the fittest, many organisms have already evolved a nearly perfect structure. This paper reviews the research status of biomimetic functional materials that use chitosan as a matrix material to mimic the biological characteristics of bivalves, biological cell matrices, desert beetles, and honeycomb structure of bees. In addition, the application of biomimetic materials in wound healing, hemostasis, drug delivery, and smart materials is briefly overviewed according to their characteristics of adhesion, hemostasis, release, and adsorption. It also discusses prospects for their application and provides a reference for further research and development.Entities:
Keywords: biomimetic materials; cell matrix; chitosan; mussels
Mesh:
Substances:
Year: 2021 PMID: 34199126 PMCID: PMC8307383 DOI: 10.3390/md19070372
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1The chitosan-based biomimetic materials and the forms of material prepared.
Proposed applications of chitosan-based materials based on forms.
| Forms | Composites | Applications | Ref. |
|---|---|---|---|
| Scaffold | CS, porous poly(ε-caprolactone) (PCL), bioactive glass (BG) polydopamine (PDA) | bone tissue engineering | [ |
| CS, graphene oxide (GO) | bone tissue engineering | [ | |
| CS, poly ( | bioengineering | [ | |
| CS, poly (methyl methacrylate-co-methacrylic acid) (P[MMA-co-MAA]), carbodiimide-crosslinker | bone tissue engineering | [ | |
| CS, honeycomb porous carbon (HPC), nano-sized hydroxyapatite (nHA), | bioengineering | [ | |
| Hydrogel | CS, catechol | biomedical fields | [ |
| CS, CS-methacrylate (CS-MA), dopamine (DA), N-methylol acrylamide (NMA) | wound healing | [ | |
| CS, HBC, DOPA | wound dressing | [ | |
| CS, DA chloride | wound healing | [ | |
| CS, catechol | biomedical fields | [ | |
| CS, catechol | biomedical fields | [ | |
| tetra-succinimidyl carbonate polyethylene glycol (PEG-4S), thiol-grafted mussel inspired catechol conjugated chitosan (CSDS) | wound healing | [ | |
| CS, methacrylate modified CS, gelatin | wound healing | [ | |
| CS-c, thiolated pluronic F-127 | tissue engineering | [ | |
| 3, 4-dihydroxyhydrocinnamic acid glycol chitosan(g-CS), CS catechol (CS-c) | biomedical fields | [ | |
| CS, catechol, diatom | biomedical fields | [ | |
| chitosan quaternary ammonium salt (HTCC), oxidized dextran-dopamine (OD-DA) | wound healing | [ | |
| glycol chitosan (GC), ciprofloxacin (Cip), PDA nanoparticles (NPs) | wound healing | [ | |
| hydroxybutyl chitosan (HBC), | wound healing | [ | |
| CS-C, β glycerol phosphate (β-GP), oyster peptides (OP) | wound dressing | [ | |
| hydrocaffeic acid (HCA)-CS, iron oxide (γ-Fe2O3) MNPs | biomedical fields | [ | |
| CS, oxidized hyaluronic acid (HAox) catechol terpolymer, Fe | wound dressing | [ | |
| CS, collagen | biomedical fields | [ | |
| CS, gelatin, compounded calcium phosphate (CCP) | bone tissue engineering | [ | |
| combiningcarboxymethyl chitosan (CMCh), amorphous calcium phosphate (ACP) | bone tissue engineering | [ | |
| Film | CS, layered double hydroxides (LDHs), | materials design | [ |
| CS, CaCO3, Al2O3 alumina platelets | hybrid materials | [ | |
| CS, PDA, silk fibroin nanofibers (SF) | biomedical fields | [ | |
| CS, delignificated nano-cellulose (DNLC), MoS2 | materials | [ | |
| CS, HCA, BGNP, catechol | biomedical fields | [ | |
| CS, alumina sheets | bionanocomposite | [ | |
| CS, montmorillonite (MTM) | bionanocomposite | [ | |
| O-carboxymethyl CS (CCS), MMT | fireproof materials | [ | |
| CS, MMT | fireproof materials | [ | |
| CS, poly (vinyl acetate) (PVAc), tetracycline (TC) | biomedical fields | [ | |
| CCS, 2-methylacrylloxyethyl phosphorycholine (MPC), PDA, GRGDY peptide | biomedical fields | [ | |
| CS, MTM, metal ions | bionanocomposite | [ | |
| CS-gelatin (C:G), anodic alumina molds (AAM) | bone tissue engineering | [ | |
| CS, poly (vinylidene fluoride) (PVDF) | wastewater treatment | [ | |
| CS, poly (ethylene glycol) diglycidyl ether (PEGDGE, Mn = 500) | glycoproteomics | [ | |
| Others | CS-c, iron oxide nanoparticles (IONPs) | biomedical fields | [ |
| carbon nanotubes (CNT), carboxymethyl CS, PDA | efficient adsorbents | [ | |
| CS, Fe3O4, PDA | efficient adsorbents | [ | |
| CMC, Fe3O4, PDA | efficient adsorbents | [ | |
| CS, CaCl2, Na2HPO4, | bone tissue engineering | [ | |
| CS, hydroxyapatite (HA), | heavy metal removal | [ | |
| CS, cis-butenediolic acid (maleic acid, MAc) | biomedical applications | [ | |
| CS, fragments of human collagen I | biomedical fields | [ | |
| CS, iron chloride hexahydrate (FeCl3·6H2O) | microwave absorbing | [ | |
| CS, HCL, KOH | absorbing materials | [ | |
| CS, aminomethyl phosphate, Ti4+ | absorbing materials | [ | |
| CS, hydroxyl-functionalized hexagonal boron nitide (OH-BN) | environment-friendly materials | [ |
Figure 2Schematic illustration of design strategy of an engineered biofilm and mussel-inspired dual-bionic adhesive hydrogels (DBAH) and its application for sealing hemostasis and wound healing. (a) The structure of polysaccharide intercellular adhesin (PIA), derived from biofilm, and DOPA, derived from mussel protein, which play a key role in wet adhesion; (b) A biometic biopolymer chitosan, grafted with methacrylate (CS-MA) from PIA; and dopamine, a catecholamine containing a catechol group of DOPA, was conjugated with NMA for hydrogel formation; (c) Schematic illustration of strong underwater bioinspired adhesion base on the self-repelling water function of CS-MA. (d) The multifunctional properties and potential application in in vivo hemorrhage and diabetic wound healing with antibacterial performance. Reproduced with permission from [27], Copyrighter Elsevier 2020.
Figure 3The mussel-like strategy provides novel approaches for wearable/implantable bioelectronics to shift from external auxiliary fixation to convenient and reliable self-adhesion. Reproduced with permission from [84], Copyrighter Wiley 2017.
Figure 4(A) Synthesis scheme of eLHBC conjugate via the binding of carboxyl groups ofl-DOPA and EPL to the NH2 groups of HBC. (B) The formation of eLHBC at 37 °C. BMSCs encapsulated into eLHBC solution at 4 °C and eLHBC as 3D BMSCs culture matrix at 37 °C (BMSCs ⊂ eLHBC). The BMSCs ⊂ eLHBC injected with a syringe on the dorsal wound site of rats and used as wound dressing. Reproduced with permission from [39], Copyrighter Elsevier 2021.
Figure 5Schematic illustration of the preparation of Fe3O4@PDA/CMC aerogel (polydopamine (PDA), dopamine (DA), Tris (hydroxymethyl)aminomethane (Tris), Carboxymethyl chitosan(CMC), and Glutaraldehyde (Glu)). Reproduced with permission from [64], Copyrighter Elsevier 2021.
Figure 6Schematic illustration of the different multifunctional (MF) and control (CTR) LbL coatings (11×: the number of repetitions required for the CTR group to alternately immerse the substrate in the oppositely-charged polyelectrolyte solutions to produce LbL coatings with 11 bilayers, i.e., 22 layers; 5×: the number of repetitions required for the MF group to alternately immerse the substrate in the oppositely-charged polyelectrolyte solutions to produce LbL coatings with 22 layers). Reproduced with permission from [50], Copyrighter Elsevier 2020.
Figure 7Preparation scheme for TC-loaded nanosheets. (i) Chitosan and sodium alginate were alternately spin coated. (ii) PVA was cast onto the LbL nanosheet. (iii) After drying PVA as a supporting layer, the nanosheet was peeled off with PVA and reversed onto the substrate. (iv) TC solution deposited on nanosheet. (v) After drying to make a TC layer, PVAc was spin coated onto the new layer. Reproduced with permission from [55], Copyrighter Elsevier 2012.
Figure 8Scheme of applied modification methods of fibrous chitosan substrates: Physical (a) electrospinning was used to apply the solution of human collagen I fragments to the CS non-woven fabric through the potential difference between the nozzle and the collector. The resulting CS with physically embedded fragments of human collagen I (CS/F K1) were fixed using lyophilization. Chemical (b), the coupling reagent, and NMM were added into the peptides solution to activate the peptide, and the non-woven sheet of CS was immersed in the solution containing active peptides to complete the reaction. After washing and drying, the covalent link fragment of the non-woven sheet of CS and human collagen I (CS/C K1) was obtained. Reproduced with permission from [68], Copyrighter Elsevier 2020.
Figure 9Design of a two-phase NP-scaffold system relying on the immobilization of P(MMA-co-MAA) NPs to a CS scaffold backbone for the sustained delivery of growth factors in bone tissue engineering applications. Reproduced with permission from [24], Copyrighter Wiley 2020.
Figure 10Schematic illustration of the preparation of PVDF-FCS. (a) The reaction for chitosan functionalization. (b) CS was anchored to pre-activated PVDF membranes by urea linker via salinization. (c) The generation of the hybrid materials. Reproduced with permission from [59], Copyrighter Elsevier 2020.
Figure 11Schematic diagram of honeycomb-shaped macroporous bionic honeycomb chitosan film preparation with a freezing casting method. Reproduced with permission from [60], Copyrighter ACS publications 2019.